Addressing the challenge of nitrosamine contamination demands a precisely customised approach to risk assessment, analytical testing, and mitigation. A one-size-fits-all solution simply is not effective.
Chemika will be exhibiting at the PDA Aseptic Manufacturing Excellence Conference on October 13-14, 2025.
Our Managing Director, Alan Doughty and Laura Piva will be at our booth to disc...
Chemika’s Analytical Development Manager, Andrew Jones, and Managing Director, Alan Doughty, attended the BIO International Convention 2025 in Boston in June.
We were proud to be part...
We’re thrilled to announce that Alan Doughty (Managing Director & Chief Chemist)
This year is EXTRA special for Chemika as we proudly celebrate 25 years of excellence in chemical testing! Since our journey began on July 1, 2000, we’ve been on an incredible trajectory – growing, evolving, and shaping the industry.<...
Chemika has expanded its leachables and extractables testing services with the recent commissioning of a triple quadrupole LCMS system.
We have been conducting extractabl...
Are material releases being delayed while your testing laboratory completes investigations?
Laboratory reporting times play a crucial role in the timely approval of incoming goods and t...
With the latest in LCMS technology, Chemika has commenced testing of pharmaceutical materials for nitrosamines. Methods have been established for a number of critical small molecule nitrosamines and we have the capability to test for ingredient...
Effective from the 3rd of November, Stephanie LeStrange has been promoted to the position of Laboratory Services Manager replacing Richard Miller in the role.
For the past few years, Stephanie has been employed in the role of Laboratory Operations ...